introduction worldwide million individual use injection drug approximately 8.5 million people india alone inject drug except union territory andaman nicobar lakshadweep injection drug use idu documented state across nation jammu kashmir estimated 25,000 people inject drug pwid injection drug use dangerous method drug abuse following injection large bolus drug instantly carried bloodstream rapidly delivered brain consequence pwid likely experience dependence overdose people abuse drug route maladaptive thought pwid negative affect undermine desire care attitude pose risk transmission blood-borne disease worldwide previous research shown heroin abused substance followed methamphetamine cocaine asia heroin commonly injected substance approximately 70–80 pwid background polydrug use india pwid opt inject one opioid drug comorbid psychiatric illness complicate treatment patient adding burden experienced pwid term comorbidity introduced medicine refer case distinct clinical course addition index illness term dual diagnosis refers coexistence specific substance use disorder sud psychiatric illness non-sud psychiatric comorbidities independent either drug use substance use illness contribute substance use disorder via combination biological environmental pathway according previous study opioid user highest prevalence dual diagnosis approximately pwid psychiatric comorbidities psychiatric patient substance use disorder polydrug abuse prevalent among pwid ascribed presence comorbid psychiatric disorder patient substance abuse psychiatric comorbidities difficult manage due variety factor multiple clinical presentation severity symptom greater number relapse poor prognosis increased hospitalization length stay higher suicide rate result lower chance recovery similarity presentation psychiatric comorbidities substance intoxication withdrawal effect make proper timely diagnosis challenging according previous study clinician frequently underdiagnose psychiatric comorbidities among drug user impact treatment plan patient result greater vigilance towards comorbidities needed managing patient substance use disorder holistic patient management decade kashmir region turmoil several study found increase prevalence psychiatric illness posttraumatic stress disorder ptsd depression due political turmoil state experienced extended lockdown period recent year resident confined home conflict traumatic experience economic development constraint breakdown conventional social support mechanism contributed psychological distress population young people represent susceptible section society variety reason including uncertainty future lack employment internet ban overwhelming fear lack self-esteem paved way rise psychiatric disorder poor coping strategy drug abuse among young people substance abuse largely gone undetected various sociocultural geographical factor play essential role onset maintenance treatment substance use disorder according recent research substance use jammu kashmir prevalence substance use 1.95 total number 25,000 pwid entire state relationship various drug psychiatric comorbidities studied various part world study injection drug abuse comorbid psychiatric disorder kashmir conducted context study carried estimate prevalence comorbid psychiatric disorder among opioid-injecting drug user furthermore study also assessed prevalence concurrent substance use association psychiatric disorder result opioid injector enrolled study 98.8 1.2 male female respectively age participant ranged year mean 25.31 5.32 year majority 57.3 study participant 15–24 age group total 36.9 participant intermediate level education 22.6 high school certificate 29.6 participant currently married study participant initiated opioid injection mean age 21.77 5.65 year peer pressure 47.9 common reason initiation injection whereas 14.6 11.3 reported initiation due curiosity pleasure respectively 64.3 participant referred treatment friend followed family 20.7 physician 9.8 opioid user 36.3 reported family history substance use psychiatric comorbidities present 88.1 majority 68.6 one psychiatric comorbidity table table baseline characteristic opioid injector full size table common psychiatric comorbidity panic disorder 41.2 followed social anxiety disorder 40.5 antisocial personality disorder 39.3 major depressive disorder 17.7 alcohol use disorder 14.6 bipolar affective disorder 8.23 obsessive–compulsive disorder psychotic disorder frequent disorder found study study participant 70.4 low intent suicidality medium high intent found 20.4 9.1 respectively table table prevalence psychiatric disorder study population full size table codeine oral tramadol tapentadol use multiple drug time opioid injector showed significant 0.05 relationship development psychiatric comorbidities using combination drug negatively associated psychiatric comorbidities people inject drug table table relationship opioids used opioid injector comorbid psychiatric condition full size table analysis showed association concurrent drug use major psychiatric disorder alcoholic beverage intake doubled risk odds ratio 2.14 1.24–3.72 aspd cannabis abuse nearly tripled odds ratio 2.95 1.28–6.80 risk mdd cannabis also increased odds ratio 1.93 1.13–3.30 risk aspd cocaine odds ratio 2.36 1.10–5.03 amphetamine odds ratio 7.68 2.21–26.65 increased risk ocd opioid injector inhalant increased risk aspd 2.5 2.59 1.55–4.33 ocd 2.4 odds ratio 2.44 1.19–5.01 table table bivariate analysis association concurrent substance use daily heroin use aspd mdd ocd among opioid injection user full size table risk developing anxiety psychiatric comorbidity increased use tobacco odds ratio 7.33 1.49–35.95 alcoholic beverage odds ratio 2.02 1.21–3.38 cannabis odds ratio 2.02 1.21–3.38 cocaine odds ratio 2.81 1.40–5.65 inhalant odds ratio 2.07 1.15–3.72 sedative odds ratio 2.30 1.43–3.69 hallucinogen odds ratio 4.13 1.70–10.06 daily heroin intake negatively associated psychotic disorder odds ratio 0.18 0.03–0.94 table table bivariate analysis association concurrent substance use daily heroin use psychiatric anxiety disorder among opioid injection user full size table binary logistic regression younger age never married status significantly associated development psychiatric comorbidities younger age adjusted odds ratio 0.20 0.79–0.53 protective factor never married status adjusted odds ratio 2.62 1.06–6.47 increased odds psychiatric comorbidities table table logistic regression analysis association demographic concurrent drug use presence psychiatric comorbidities full size table discussion comorbid psychiatric illness injection drug use complicate management put caregiver affected individual difficult situation understanding issue psychiatric comorbidities concurrent substance use among opioid people inject drug important context pharmacotherapy improved treatment outcome majority participant male participant 15–24 age group mean age 5.32 year half participant never married majority lived nuclear family sociodemographic profile participant similar participant previous study conducted yasir andreecia trouiller similar finding reported nizam din study substance user however study conducted andreecia majority participant married older study also included participant year age could partly explain lower age distribution never married status participant equal representation subject nuclear joint family reported yasir study 79.9 nuclear family explained difference setting community vs. hospital-based study conducted study participant injecting heroin yasir hassan trouiller also reported 91.12 heroin user among pwid respectively however armstrong found buprenorphine major injectable heroin participant might related availability heroin study area nearly participant used tobacco product last three month alcoholic beverage cannabis sedative used 74.7 74.1 50.9 participant respectively however finding differed study conducted andreecia commonly abused substance barring tobacco product opioids cannabis followed alcohol result study yasir reported lifetime use cannabis alcohol sedatives-hypnotics 50.33 21.33 18.33 participant respectively difference prevalence use substance study study yasir could current study based exclusively opioid injector average age initiation injection drug use among study participant 21.77 5.65 year delhi-based study gregory armstrong average age initiation lower 15.8 year age variation explained difference study population targeted researcher study community-based targeted hidden group high injecting behaviour opposed study peer pressure main reason injecting behaviour among majority participant followed curiosity fun agreement finding study conducted samina farhat pressure conform others powerful hard resist person might feel pressure something others peer pressure influence person something relatively harmless something serious consequence negative influence peer group connected involvement risk behaviour daily heroin use last month reported 94.2 participant study silvia tortajada majority study participant used injection drug one two day week 16.2 used every day nearly one-third participant family history substance use another important finding current study friend major path referral treating one injection drug user motivation seeking treatment among pwid creating positive cycle study psychiatric comorbidities found 88.1 participant similar finding study conducted part india farooqui mohanty 98.6 77.5 participant psychiatric comorbidities respectively difference prevalence explained difference measurement tool used study study west reported lower prevalence psychiatric morbidity 52.7 angelo giovanni silvia tortajada approximately two-thirds study participant one psychiatric comorbidity however slightly higher number study conducted farooqui high burden psychiatric comorbidities requires rigorous assessment pwid multiple disorder substance use disorder anxiety disorder comprising panic disorder agoraphobia social anxiety disorder generalized anxiety disorder found participant 66.5 slightly higher prevalence anxiety disorder also found study gregory armstrong study significantly low prevalence anxiety disorder higher prevalence anxiety disorder explained unrest kashmir covid-19 pandemic study period nearly one-third 39.3 participant antisocial personality disorder finding consistent study robert brooner study darke community-based methadone patient prison inmate enrolled prison methadone program prison inmate history heroin use interviewed obtain diagnosis antisocial personality disorder aspd psychopathy reported community-based methadone patient aspd similar finding study furthermore history injecting drug increase odds diagnosed antisocial personality disorder factor 21.01 aspd pose major challenge health care provider outcome remains poor major depressive disorder found 17.7 study population similar prevalence depressive disorder found study trouiller 21.3 margoob mary mackesy-amiti participant study psychotic disorder ptsd found 8.5 study participant line finding margoob finding could attributed local political unrest cause trauma discontent study suicidality excluding low intent experienced 29.5 participant study iskandar showed prevalence suicidal ideation suicide attempt ranging 43–87 respectively substantial variation prevalence suicidality study suicidality difficult compare owing different risk assessment method employed different researcher inclusion low intent calculating prevalence bivariate analysis co-occurring substance use codeine oral tramadol tapentadol use multiple drug time pwid showed significant relationship development psychiatric comorbidities surprisingly using combination opioids single point time protected psychiatric condition people inject drug finding polysubstance use increase psychiatric comorbidities pwid line study fischer mackesy-amiti polysubstance use associated psychiatric comorbidities cannabis use significantly associated major depressive disorder agreement study daniel feingold john horwood potential genetic correlation contributing comorbidity cannabis dependence major depression serotonin 5-ht may mediate association also evidence specific risk allele cannabis addiction study cocaine amphetamine inhalant use positively associated obsessive–compulsive disorder daily heroin intake negatively associated psychotic disorder finding similar study trouiller daily heroin use negatively associated major depressive disorder psychotic disorder pwid hypothesis antipsychotic modulatory effect opioids dopamine neurotransmitter system control mood suggested substance except amphetamine daily heroin intake found significantly associated anxiety disorder binary logistic regression younger age protective psychiatric comorbidities explained cumulative effect substance time development psychiatric comorbidities also call need early intervention among people inject drug prevent development psychiatric disorder never married also associated psychiatric comorbidities hypothesis finding ascribed lack social support rebecca brienza found opioid user without current partner likely depressed partner strength limitation one first study kashmir valley focus identifying psychiatric comorbidities special group people inject drug study used nationally internationally approved tool data collection study also identified various demographic characteristic use concurrent substance development psychiatric comorbidities among opioid injector included patient younger previously included study addition prevalence single multiple comorbidities routinely reported earlier study calculated study study also limitation single-centre study cross-sectional design study analyse dependence substance opioids furthermore study included pwid seeking medical help hence result extrapolated group conclusion study concluded addition injecting opioids substantial number pwid used multiple substance time higher percentage multiple psychiatric comorbidities prevalent among pwid used opioids anxiety disorder panic disorder social anxiety disorder agoraphobia generalized anxiety disorder frequent psychiatric comorbidities followed antisocial personality disorder use opioids codeine tramadol tapentadol multiple opioids time associated higher frequency psychiatric comorbidities furthermore concurrent use substance tobacco cannabis cocaine inhalant sedative alcoholic beverage significantly increased odds psychiatric comorbidities younger age use combination opioids negatively associated psychiatric comorbidities future research cover pwid also focus medical comorbidities quality life pwid psychiatric comorbidities result study suggest physician treating pwid mindful psychiatric comorbidities risk factor associated condition patient care recommendation study recommends routine screening opioid injector psychiatric comorbidities general physician treat pwid deaddiction centre refer pwid identification psychiatric comorbidities relevant specialist treating physician especially focus patient history prolonged injection drug use older patient using multiple drug patient never married referral policy-makers include mandatory screening pwid psychiatric comorbidities deaddiction program method study conducted deaddiction centre addiction treatment facility one medical college summer capital jammu kashmir india single-centre hospital-based cross-sectional study carried march august pwid history injection substance use least last month seeking treatment recruited study people age group sex included study pwid identified urine drug screening card test injection mark terminally ill patient suffering life-threatening illness pregnant female excluded study sample size sampling procedure online raosoft sample size calculation software used determine sample size sample size research based prevalence previous study reported pwid psychiatric comorbidities confidence interval allowable error required sample size study participant recruited using consecutive sampling method researcher began inviting single participant obtaining informed consent collecting data moving next participant next participant declined participate researcher extended invitation different participant arrived seek treatment data collection sociodemographic profile participant recorded data collection sheet approved national survey pattern extent substance use semi-structured proforma covered question path referral age initiation opioid injecting behaviour reason injecting opioids family history substance use participant addition who-assist used ass frequency opioid injection previous attempt reduce opioid use presence co-occurring substance use mini international neuropsychiatric interview-7 mini-7 used ensure uniformity diagnosis psychiatric disorder mini-7 short structured diagnostic interview developed evaluating common psychiatric disorder clinical research setting various disorder included depressive disorder bipolar affective disorder suicidality anxiety disorder obsessive–compulsive disorder psychotic disorder eating disorder posttraumatic stress disorder antisocial personality disorder take approximately min administer mini-7 updated version mini corresponding dsm-5 widely used tool mental health professional health organization country ass comorbid psychiatric disorder mini- 7.02 administered participant noted excluded suicidality calculating total prevalence psychiatric comorbidities participant diagnosed mental health disorder offered psychiatric follow-up psychiatric outpatient department opd researcher received necessary training face-to-face interview department psychiatry potential participant approached participate purpose study procedure involved voluntary nature participation explained patient confidentiality data assured statistical analysis statistical package social science spss version spss chicago u.s.a. used data analysis data coded double checked entry result presented frequency percentage categorical variable mean standard deviation continuous variable bivariate analysis carried using fisher exact test chi square test without yates correction odds ratio confidence interval ass relationship sociodemographic characteristic concurrent use substance major psychiatric comorbidities logistic regression carried using enter method identify variable predicting psychiatric comorbidities adjusted odds ratio calculated presented relevant table value 0.05 considered significant study ethic statement institutional ethical committee skim medical college srinagar iec skim medical college approved research protocol protocol iec/43/2021 dated 26th march informed consent informed consent obtained participant and/or parents/guardians interview research performed accordance local guidelines/regulations accordance declaration helsinki participation voluntary data collected anonymous